Exelixis EXEL
-
Exelixis' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Exelixis , Inc. ( EXEL ) Bank of America Merrill Lynch Health Care ..... Morrissey, our Chief Executive Officer of Exelixis . But before Michael starts speaking ..... seekingalpha.com/article/1434671- exelixis -ceo-presents-at-bank-of …
-
New Morningstar Analyst Report for Biogen Idec Inc
… after serving as CEO of development-stage biotech Exelixis EXEL for 14 years. While we see this as an unconventional ..... commercial operations, we think his performance at Exelixis demonstrates a strong understanding of business development …
-
Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
By C.R. Jackson : Boulder, Colorado-based Array BioPharma Inc. ( ARRY ) is a $594M market cap biopharmaceutical company that discovers, develops and commercializes targeted small molecule drugs to treat cancers and inflammatory diseases. The company believes that there is significant synergy ...
-
Exelixis' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Exelixis , Inc. ( EXEL ) Q1 2013 Earnings Call May 07, 2013 ..... and welcome to the Quarter One 2013 Exelixis , Inc. Earnings Conference Call. My ..... seekingalpha.com/article/1412361- exelixis -ceo-discusses-q1-2013-results …
-
Notable earnings after Tuesday’s close: [[ANDE]], [[ARAY]], [[AWK]], [[AXLL]], [[BIO]], [[BIOL]], [[BMC]], [[BWC]], [[CA]], [[CDXS]], [[CHRW]], [[CODI]], [[DGI]], [[DGIT]], [[DIS]], [[DVA]], [[EA]], ...
… s close: ANDE , ARAY , AWK , AXLL , BIO , BIOL , BMC , BWC , CA , CDXS , CHRW , CODI , DGI , DGIT , DIS , DVA , EA , ENPH , EXEL , GTEK, GA , GPOR , IAG , JAZZ , KGC , LYV , MAKO , MCEP , MCK , MDLZ , MITK , MRO , MYGN , NVTL , OAS , OCLR , OHI , ONXX …
-
Notable earnings after Tuesday’s close: [[ANDE]], [[ARAY]], [[AWK]], [[AXLL]], [[BIO]], [[BIOL]], [[BMC]], [[BWC]], [[CA]], [[CDXS]], [[CHRW]], [[CODI]], [[DGI]], [[DGIT]], [[DIS]], [[DVA]], [[EA]], ...
… s close: ANDE , ARAY , AWK , AXLL , BIO , BIOL , BMC , BWC , CA , CDXS , CHRW , CODI , DGI , DGIT , DIS , DVA , EA , ENPH , EXEL , GTEK, GA , GPOR , IAG , JAZZ , KGC , LYV , MAKO , MCEP , MCK , MDLZ , MITK , MRO , MYGN , NVTL , OAS , OCLR , OHI , ONXX …
-
Beware 5-Star Stocks Bearing No Moats
… production and the weighted average cost of capital, which is why the stock carries a high fair value uncertainty rating. Exelixis EXEL Although biotech companies as a group are overvalued, according to Morningstar estimates, this maker of cancer treatments …
-
Cramer's Lightning Round- Kicking Myself Over Toll Brothers (4/16/13)
… Financial ( GNW ), Radian ( RDN ): "People don't realize Genworth has a Radian type of business, and Radian is one of my favorite specs right now. Both (GNW and RDN) can go higher." Exelixis ( EXEL ): "This is a good Complete Story »
-
Where Is Exelixis In The Cancer Therapeutics Market?
… R. Jackson: If you invest in Exelixis , Inc. ( EXEL ) , you better be a believer ..... unprecedented." If you invest in Exelixis , you should be a long-term ..... the market was very fond of Exelixis . In March 2011, Exelixis shares …
-
New Morningstar Analyst Report - Pacer International, Inc.
… the retail intermodal services unit, with 20-plus years of experience in transportation and logistics (including roles at Exel Logistics and Kansas City Southern). CFO John Hafferty joined in March 2010, previously serving as CFO of international operations …